AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04181606 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pre exercise baseline
Description: Subject rests quietly while drug infusion begins (3 min loading dose followed by 10 min of maintenance dose) until heart rate and blood pressure stabilize.
Study NCT04181606 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Pre exercise baseline
Description: Subject rests quietly while drug infusion begins (3 min loading dose followed by 10 min of maintenance dose) until heart rate and blood pressure stabilize.
Study NCT04181606 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Isometric handgrip exercise
Description: The subject will grip at 40% of their maximum and maintain that grip for 90 seconds. Once at rest and once during heavy intensity cycling.
Study NCT04181606 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Isometric handgrip exercise
Description: The subject will grip at 40% of their maximum and maintain that grip for 90 seconds. Once at rest and once during heavy intensity cycling.
Study NCT04181606 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Semi-recumbent cycling
Description: Subjects will pedal for 2-4 minutes at a very light intensity (20W), followed immediately by 5 minutes at a moderate intensity (at a workload intended to elicit 85% of the oxygen consumption observed at the lactate threshold), and 5 minutes of cycling at a heavy intensity (at a workload estimated to elicit oxygen consumption half way between those observed at the lactate threshold and respiratory compensation point). Subjects will then continue cycling at the heavy intensity for 90 seconds while performing isometric handgrip exercise.
Study NCT04181606 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Semi-recumbent cycling
Description: Subjects will pedal for 2-4 minutes at a very light intensity (20W), followed immediately by 5 minutes at a moderate intensity (at a workload intended to elicit 85% of the oxygen consumption observed at the lactate threshold), and 5 minutes of cycling at a heavy intensity (at a workload estimated to elicit oxygen consumption half way between those observed at the lactate threshold and respiratory compensation point). Subjects will then continue cycling at the heavy intensity for 90 seconds while performing isometric handgrip exercise.
Study NCT05727618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pituitrin
Description: The specification of posterior pituitary injection is 1ml/6U, diluted with normal saline to 0.5u/ml, and injected by intravenous pump at the rate of 0.04u/ (kg · h).
Study NCT05727618 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: Intravenous infusion of normal saline at the same dose and speed
Study NCT04935112 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Famotidine
Description: 40 mg PO 2 hrs after sitravatinib in Period 2 of Group 2
Study NCT04798209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 14C-ACT-777991 microtracer (MAD - ADME)
Description: Single dose of 14C-ACT-777991 microtracer, oral solution..
Study NCT04798209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Microtracer matching placebo (MAD - ADME)
Description: Single dose of 14C-ACT-777991 microtracer matching placebo, oral solution.
Study NCT06505096 — intervention group
Intervention type: PROCEDURE
Intervention: cataract surgery
Description: Phaco+IOL implention
Study NCT05441956 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TGRX-326
Description: Participants are given TGRX-326 tablets orally at one of the dose levels as pre-determined.
Study NCT04667585 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: De-escalated radiation dose
Description: Reduced dose of radiation applied to remaining radiation therapy when favorable interim PET-CT signature is produced
Study NCT04667585 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Standard radiation dose
Description: Standard dose of radiation applied to remaining radiation therapy when favorable PET-CT signature is not produced
Study NCT04667585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 18 fluorodeoxyglucose (FDG)-positron emission tomography (PET)-Computed Tomography (CT)
Description: The CT scan - also called computerized tomography or just CT - combines a series of X-ray views taken from many different angles to produce cross-sectional images of the bones and soft tissues inside the body. CT scans in planning radiation therapy are standard of care. A PET is a highly specialized imaging technique that uses short-lived radioactive substances (such as FDG a simple sugar labeled with a radioactive atom) to produce three-dimensional colored images of those substances functioning within the body. These images are called PET scans and the technique is termed PET scanning. PET scanning provides information about the body's chemistry not available through other procedures. Unlike CT or MRI (magnetic resonance imaging), techniques that look at anatomy or body form, PET studies metabolic activity or body function.
Study NCT04667585 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 18 fluorodeoxyglucose (FDG)-positron emission tomography (PET)-Computed Tomography (CT)
Description: The CT scan - also called computerized tomography or just CT - combines a series of X-ray views taken from many different angles to produce cross-sectional images of the bones and soft tissues inside the body. CT scans in planning radiation therapy are standard of care. A PET is a highly specialized imaging technique that uses short-lived radioactive substances (such as FDG a simple sugar labeled with a radioactive atom) to produce three-dimensional colored images of those substances functioning within the body. These images are called PET scans and the technique is termed PET scanning. PET scanning provides information about the body's chemistry not available through other procedures. Unlike CT or MRI (magnetic resonance imaging), techniques that look at anatomy or body form, PET studies metabolic activity or body function.
Study NCT04977076 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Uninterrupted NOAC use
Description: Continuing NOAC use in advance of elective CAG or PCI.
Study NCT02918708 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Synflorix
Description: 10-valent pneumococcal conjugate vaccine
Study NCT02918708 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevenar13
Description: 13-valent pneumococcal conjugate vaccine
Study NCT05527886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AAROM
Description: AAROM with knee to wall exercise, 3x30 reps
Study NCT05527886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Slow Load
Description: Single leg heel raise, 3x10 reps
Study NCT05527886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plyometric
Description: Double leg 5 inch wall hops, 3x10 sec
Study NCT06282601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Audiogram
Description: Tonal and vocal free-field without lip-reading
Study NCT06282601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Musical priming for the syntax test
Description: Listening to music with a regular or irregular rhythm, then judging the grammaticality of 2x6 blocks of French sentences interrupted by a pause, each block presenting 4 sentences including 2 grammatically correct sentences and 2 grammatically incorrect sentences. The sentences are pronounced by a French female voice at a natural rhythm and comfortable volume.
Study NCT06282601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Test MMSE
Description: test to assess a person's cognitive functions and memory capacity.
Study NCT06282601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Barcelona Music Reward Questionnaire
Description: 20 questions exploring 5 main facets of the musical reward experience, with 4 items for each of the 5 facets, for which participants indicate the level of agreement using a 5-level scale, ranging from strongly disagree to strongly agree.
Study NCT05035589 — intervention group
Intervention type: DRUG
Intervention: Tocilizumab
Description: Tocilizumab administered at a dose of 8mg/kg up to a maximum of 800mg
Study NCT05288140 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: use of diary
Description: a diary is made for the experimental group where the events and events during the period of sedation and intubation are explained
Study NCT04977076 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interrupted NOAC use
Description: Usual care, interruption of NOAC prior to procedure.
Study NCT05637749 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical serious game intervention (educational)
Description: Medical serious game designed to facilitate the rehearsal of diabetes management knowledge. Players are presented with a colony of individuals, all of whom have some form of diabetes, and are tasked to manage food, insulin, and medication intake throughout the day. The intervention may be played with a facilitator.
Study NCT05637749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical serious game intervention (educational)
Description: Medical serious game designed to facilitate the rehearsal of diabetes management knowledge. Players are presented with a colony of individuals, all of whom have some form of diabetes, and are tasked to manage food, insulin, and medication intake throughout the day. The intervention may be played alone.
Study NCT05365984 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: end tidal carbon monoxide corrected for ambient carbon monoxide （ETCOc）
Description: The measurement of end tidal carbon monoxide corrected for ambient carbon monoxide （ETCOc）is conducted in the process of risk evaluation.
Study NCT05365984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internet Plus technology
Description: The Internet Plus technology is applied in the process of follow-up management.
Study NCT04708938 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High voltage electrical stimulation+exercise therapy
Description: The effect of high voltage electrical stimulation on temporomandibular disorders
Study NCT04708938 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise therapy
Description: The effect of high voltage electrical stimulation on temporomandibular disorders
Study NCT06001554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interaction Competencies with Children - for Teachers (ICC-T)
Description: Core training components include teacher-student interaction, maltreatment prevention, effective discipline strategies, identifying and supporting burdened students and implementation of the training materials into the school setting
Study NCT04322747 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Distortion product otoacoustic emissions (DPOAE)
Description: Audiometry for extended high frequencies, DPOAE, and, ECochG measurements will be collected before and after skull-based surgeries.
Study NCT05190380 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HIGH INTENSITY PROGRESSIVE RESISTED EXERCISE
Description: Intervention:Leg presses, knee extension, hip adduction and hip abduction exercises will be performed by patients. There will be a warm up sets for 1 repetition maximum with 2 min gap between both sets (leg press + knee extension exercises) (hip abduction and hip adduction) patients will ask to perform.~Both groups will receive routine physical therapy (Tens, Hot pack, Deep friction massage) in addition with experimental interventions
Study NCT05190380 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LOW INTENSITY PROGRESSIVE RESISTED EXERCISE
Description: Intervention:Leg presses, knee extension, hip adduction and hip abduction exercises will be performed by patients. There will be a warm up sets for 1 repetition maximum with 2 min gap between both sets (leg press + knee extension exercises) (hip abduction and hip adduction) patients will ask to perform.~Both groups will receive routine physical therapy (Tens, Hot pack, Deep friction massage) in addition with experimental interventions
Study NCT05750901 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Fractional ablative laser
Description: Fractional ablative laser used for treatment for skin laxity and tightening
Study NCT05555914 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurostimulation
Description: Implantation of 3 multicontact cuff electrodes in the upper limb of patients with tetraplegia and control of the stimulation by contralateral shoulder movements
Study NCT05257343 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Liquid Placebo Supplementation
Description: 8-weeks of supplementing with a visually identical liquid placebo supplement.
Study NCT05257343 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Liquid Iron Supplement (Blood Builder ®)
Description: 8-weeks of supplementing with a liquid iron supplement (Blood Builder ®)
Study NCT05403229 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate
Description: The topiramate arm receives additional oral topiramate for 6 weeks. The dose of topiramate is started from 25mg orally daily with the weekly escalation of 25mg to a maximum of 100mg.
Study NCT05575349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandala coloring
Description: Participants will be asked to choose the pages they want from 12 colored felt-tip pen paint sets and 12 mandala coloring pages given to each participant by the researcher for 6 weeks, 1 days a week, at any time of the day and for an average of 20-30 minutes each time, and paint them in the colors they want.
Study NCT05403229 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic Steroids
Description: Both groups receive a systemic steroid with/without intratympanic steroids as the standard treatment of SSNHL.
Study NCT05403229 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Systemic Steroids
Description: Both groups receive a systemic steroid with/without intratympanic steroids as the standard treatment of SSNHL.
Study NCT05042609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TRS01
Description: TRS01 eye drops Dosed four times a day (QID)
Study NCT05042609 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FDA approved steroid eye drop (masked)
Description: FDA approved steroid eye drop Dosed four times a day (QID)
Study NCT06371534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QL2109
Description: subcutaneous injection 3-5 min D1 (Day 1, single dose)
Study NCT06371534 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DARZALEX FASPRO®
Description: subcutaneous injection 3-5 min D1 (Day 1, single dose)
Study NCT05505604 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PENG
Description: patients will receive an ultrasound-guided Pericapsular Nerve Group Block with 20mL of 0.25% bupivacaine (not to exceed 2mg/kg)
Study NCT05505604 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: FICB
Description: Patients will receive an ultrasound-guided Fascia Iliaca Compartment Block with 20 mL of 0.25% bupivacaine (not to exceed 2 mg/kg) diluted to total volume of 40 mL of injectate
Study NCT05224037 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: iLivTouch
Description: Eligible subjects will undergo liver stiffness and controlled attenuation parameters examination with two devices on the same day
Study NCT05989659 — intervention group
Intervention type: OTHER
Intervention: Exposure: Home dialysis or facility-hemodialysis
Description: Initiation of dialysis with home dialysis (peritoneal dialysis or home hemodialysis) or facility-hemodialysis
Study NCT05378074 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maxipost
Description: Study participants will be allocated to receive continuous intravenous infusion of 0.05 mg/min MaxiPost.
Study NCT05234489 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Signature Cord Prime
Description: Low dose - Subjects will receive SIG001 (75 mg) which will be diluted to a total of 4 ml volume with Ringer's Lactate.~High dose - Subjects will receive SIG001 (150mg) which will be diluted to a total of 4 ml volume with Ringer's Lactate.
Study NCT06052943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Intervention
Description: Learning 2 BREATHE (L2B) is an evidence based curriculum for adolescents. L2B in this program consists of 6 sessions of approximately 1 hour per session. In between sessions, participants are asked to practice brief mindfulness skills individually.
Study NCT05909618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
Description: 5 mg/kg solution for injection
Study NCT05909618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
Description: 3 mg/mL solution for injection
Study NCT06052943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Education
Description: The parent education curriculum includes 3 modules: 1) family support/parenting, 2) nutrition and 3) physical activity. The parents set weekly goals to implement the parent education lessons into everyday living.
Study NCT06052943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity
Description: Combines aerobic and resistance training though game play.
Study NCT06052943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Mindfulness Intervention for Parents
Description: Parent-based mindfulness education based on the Learning to BREATHE curriculum.
Study NCT06052943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preschool Curriculum
Description: Preschool age children learn about and try new foods.
Study NCT06052943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cooking Matters
Description: Nutrition education and hands-on cooking lessons for the whole family
Study NCT06405906 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fat-free diet
Description: The low-fat diet will consist of instructions to avoid fatty foods.
Study NCT06405906 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balanced WHO diet
Description: The balanced WHO diet will adhere to the recommendations of the World Health Organization (WHO) and the Dietary Guidelines for Americans 2020-2025
Study NCT05378074 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Study participants will be allocated to receive continuous intravenous infusion of 20 mL placebo (isotonic saline).
Study NCT05878106 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Description: 5 g/day supplementation of creatine for the duration of the exercise the 16-week intervention.~The RG and the RCG will receive a supplement of soluble protein powder (20-30 g) daily.
Study NCT05878106 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: They will do resistance training. Resistance training will be a 16-week supervised workout that will consist of a series of resistance exercises (leg press, knee extension, knee bends, chest press, sit-ups, back extensions, pull-ups, and shoulder press) that involved the largest muscle groups of the body and will be performed three times a week on non-consecutive days.
Study NCT05571774 — intervention group
Intervention type: OTHER
Intervention: collection data
Description: collection data
Study NCT06216249 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PSMA PET/CT, SPECT/CT, PET/CT and CT
Study NCT06216249 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo PSMA PET/CT, SPECT/CT, PET/CT and CT
Study NCT06216249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gallium Ga 68 Gozetotide
Description: Given IV
Study NCT06216249 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gallium Ga 68 Gozetotide
Description: Given IV
Study NCT06216249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lutetium Lu 177 Vipivotide Tetraxetan
Description: Given IV
Study NCT06216249 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lutetium Lu 177 Vipivotide Tetraxetan
Description: Given IV
Study NCT06216249 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT06216249 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT06216249 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PSMA PET Scan
Description: Undergo PSMA PET/CT
Study NCT06216249 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PSMA PET Scan
Description: Undergo PSMA PET/CT
Study NCT06216249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06216249 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06216249 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Photon Emission Computed Tomography
Description: Undergo SPECT/CT
Study NCT06216249 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single Photon Emission Computed Tomography
Description: Undergo SPECT/CT